Clinical Trial Update: Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting [Phase 2]

View source ↗

Summary

Phase 2 trial update of an insulin-plus-pramlintide closed-loop strategy for Type 1 diabetes to regulate glucose without carbohydrate counting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• pramlintide (pramlintide)

Snippet

Sponsor: McGill University | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED